UTERINE SEROUS CARCINOMA
Clinical trials for UTERINE SEROUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE SEROUS CARCINOMA trials appear
Sign up with your email to follow new studies for UTERINE SEROUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in battling Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new oral drug, VLS-1488, in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if it can shrink tumors or slow cancer growth. About 200 adults with specific cancers like ovarian, lung, or breas…
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 07:00 UTC
-
New hope for rare uterine cancer: targeted drug trial launches
Disease control Recruiting nowThis study tests a drug called azenosertib in 25 women whose uterine serous carcinoma has come back or not gone away. The drug blocks a protein (Wee1) that cancer cells need to grow. Researchers will check if the drug slows tumor growth and look at how it affects cancer cells in …
Matched conditions: UTERINE SEROUS CARCINOMA
Phase: PHASE2 • Sponsor: Joyce Liu, MD • Aim: Disease control
Last updated May 12, 2026 13:40 UTC